Galaxy Medicare profit drops 24% despite higher revenue
Key highlights
- Galaxy Medicare’s first-half profit fell about 24% to Rs 1.53 crore.
- Revenue from operations increased to Rs 20.19 crore from Rs 18.73 crore a year earlier.
- Inventories rose by Rs 2.85 crore to Rs 8.47 crore at September 30, 2026.
- Galaxy Medicare reported Rs 65.38 lakh in operating cash flow and a Rs 50 lakh IPO-related advance recoverable.
powered by IRIS

Galaxy Medicare Limited reported a 24% fall in profit to Rs 1.53 crore for the half year ended September 30, 2026, even as revenue from operations rose to Rs 20.19 crore from Rs 18.73 crore a year earlier. Total expenses increased by Rs 2.77 crore, exceeding the Rs 2.17 crore increase in total income.
Know Galaxy Medicare inside out
Results, valuation, peers and who's buying, in one view.
Why did Galaxy Medicare’s first-half profit decline?
Galaxy Medicare’s first-half profit declined because expenditure grew faster than income. Total income increased to Rs 21.24 crore in the half year ended September 30, 2026, from Rs 19.06 crore in the corresponding half year a year earlier, while total expenses rose to Rs 19.06 crore from Rs 16.29 crore. Profit before tax therefore fell to Rs 2.18 crore from Rs 2.78 crore.
Materials consumed accounted for the largest year-on-year cost increase, rising by Rs 2.29 crore to Rs 13.89 crore. Purchases of traded goods increased to Rs 81.63 lakh from Rs 52.63 lakh, other expenses rose to Rs 2.63 crore from Rs 2.31 crore, and depreciation and amortisation increased to Rs 39.78 lakh from Rs 29.87 lakh. Finance costs also rose to Rs 16.03 lakh from Rs 11.44 lakh.
The company reported profit for the period of Rs 1.53 crore, compared with Rs 2.02 crore in the half year ended September 30, 2025. Current tax expense was Rs 53.30 lakh, versus Rs 71.63 lakh a year earlier, while deferred tax was Rs 12.01 lakh, compared with Rs 4.05 lakh. The lower tax charge did not offset the decline in profit before tax.
How did Galaxy Medicare’s revenue compare with prior periods?
Galaxy Medicare increased revenue from operations by Rs 1.46 crore year on year to Rs 20.19 crore in the September 2026 half year. Other income rose to Rs 1.05 crore from Rs 33.30 lakh, lifting total income by Rs 2.17 crore. The results statement does not provide a revenue split by product because Galaxy Medicare says it operates in a single segment.
Galaxy Medicare’s September-half revenue was below the immediately preceding half year ended March 31, 2026. Revenue from operations in that March half was Rs 21.27 crore, Rs 1.08 crore above the September 2026 figure, while profit for the period was Rs 1.58 crore, Rs 5.51 lakh higher than the latest half-year result. The company says the March 2026 half-year figures are balancing figures based on audited full-year results and the September 2025 unaudited figures.
Inventory-change entries in the income statement reduced costs during the September 2026 half year. Finished-goods inventory change was negative Rs 9.22 lakh, work-in-progress change was negative Rs 1.02 crore and stock-in-trade change was negative Rs 30.68 lakh. In the year-earlier half, the respective entries were negative Rs 23.82 lakh, negative Rs 65.13 lakh and negative Rs 15.96 lakh.
Got a follow-up? Ask IRIS
What changed in Galaxy Medicare’s working capital?
Galaxy Medicare’s inventory balance rose to Rs 8.47 crore at September 30, 2026 from Rs 5.62 crore at March 31, 2026. Its cash-flow statement recorded Rs 2.85 crore of cash used in inventories during the half year, the largest disclosed working-capital outflow. This inventory movement differs from the negative inventory-change entries in the income statement because those entries measure production and stock-cost movements rather than the period-end balance alone.
Trade receivables declined to Rs 6.38 crore from Rs 7.62 crore over the six months, and the cash-flow statement recorded a Rs 1.24 crore inflow from receivables. Trade payables increased to Rs 2.36 crore from Rs 1.77 crore, producing a stated cash inflow of Rs 1.31 crore. Those inflows partly offset the inventory build and a Rs 1.02 crore cash outflow attributed to other current assets.
Short-term borrowings fell to Rs 3.50 crore at September 30 from Rs 3.71 crore at March 31. Shareholders’ funds increased to Rs 41.34 crore from Rs 40.34 crore, while total assets increased to Rs 51.49 crore from Rs 48.77 crore. Property, plant and equipment was broadly unchanged at Rs 15.00 crore, compared with Rs 15.03 crore at the previous financial year-end.
What did Galaxy Medicare disclose about cash flow and IPO funds?
Galaxy Medicare generated net operating cash flow of Rs 65.38 lakh in the half year ended September 30, 2026, after income taxes paid of Rs 53.30 lakh. Profit before working-capital changes was Rs 2.03 crore. Cash released from receivables and trade payables was outweighed in part by inventory and other-current-asset movements.
Investing activities used Rs 32.79 lakh, including Rs 40.20 lakh spent on fixed assets and Rs 60.27 lakh invested in fixed deposits. Financing activities used Rs 37.90 lakh, including interest paid of Rs 16.03 lakh and a Rs 21.19 lakh reduction in short-term borrowings. Cash and cash equivalents under the cash-flow statement decreased by Rs 5.29 lakh to Rs 3.21 lakh at the end of the period.
Galaxy Medicare disclosed a Rs 50 lakh advance paid to its book-running lead manager before receipt of initial public offering, or IPO, proceeds. The company said the lead manager had not adjusted the advance while recovering IPO fees from the escrow collection account, so the amount remains classified as an advance recoverable under short-term loans and advances. The statutory auditor drew attention to the item but did not modify its review conclusion.
Galaxy Medicare separately said there was no deviation or variation in the use of IPO proceeds during the half year ended September 30, 2026. The company said its audit committee reviewed the statement and its board took it on record on November 14, 2026. Shareholders had approved a final dividend of Rs 3.50 per equity share for financial year 2025-26, totalling Rs 53.10 lakh, which Galaxy Medicare said it paid on October 17, 2026.
Conclusion
Galaxy Medicare’s September 2026 half-year results show that higher operating revenue did not translate into higher earnings. Revenue from operations rose by Rs 1.46 crore, but total expenses rose by Rs 2.77 crore, led by a Rs 2.29 crore increase in materials consumed. The balance sheet also recorded a Rs 2.85 crore increase in inventories, while receivables declined and payables increased.
The next disclosed matters to watch are the unresolved Rs 50 lakh advance recoverable from the book-running lead manager and future disclosures on IPO-proceeds utilisation. Galaxy Medicare reported no deviation or variation in IPO fund use as of September 30, 2026, while the board approved the unaudited half-year results on November 14, 2026 after the statutory auditor’s limited review.


